Works matching IS 10837159 AND DT 2017 AND VI 22 AND IP 7

Results: 20

A Case of Metastatic Atypical Neuroendocrine Tumor with ALK Translocation and Diffuse Brain Metastases.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 768, doi. 10.1634/theoncologist.2017-0054
By:
- Wang, Victoria E.;
- Young, Lauren;
- Ali, Siraj;
- Miller, Vincent A.;
- Urisman, Anatoly;
- Wolfe, John;
- Bivona, Trever G.;
- Damato, Bertil;
- Fogh, Shannon;
- Bergsland, Emily K.
Publication type:
Article
Oncofertility: Fertile Ground for Conflict Between Patient Autonomy and Medical Values.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 860, doi. 10.1634/theoncologist.2016-0373
By:
- Walsh, Sarah K.;
- Ginsburg, Elizabeth S.;
- Lehmann, Lisa Soleymani;
- Partridge, Ann H.
Publication type:
Article
BRAF Mutations as Predictive Biomarker for Response to Anti-EGFR Monoclonal Antibodies.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 864, doi. 10.1634/theoncologist.2017-0031
By:
- van Brummelen, Emilie M. J.;
- de Boer, Anthonius;
- Beijnen, Jos H.;
- Schellens, Jan H. M.
Publication type:
Article
Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 782, doi. 10.1634/theoncologist.2017-0069
By:
- Siano, Marco;
- Molinari, Francesca;
- Martin, Vittoria;
- Mach, Nicolas;
- Früh, Martin;
- Freguia, Stefania;
- Corradino, Irene;
- Ghielmini, Michele;
- Frattini, Milo;
- Espeli, Vittoria
Publication type:
Article
National Policies Fostering Hospice Care Increased Hospice Utilization and Reduced the Invasiveness of End-of-Life Care for Cancer Patients.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 843, doi. 10.1634/theoncologist.2016-0367
By:
- Shao, Yu‐Yun;
- Hsiue, Emily Han‐Chung;
- Hsu, Chih‐Hung;
- Yao, Chien‐An;
- Chen, Ho‐Min;
- Lai, Mei‐Shu;
- Cheng, Ann‐Lii
Publication type:
Article
ALK Fusion Detection in Circulating Free DNA: Finding an Important Needle in the Haystack.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 759, doi. 10.1634/theoncologist.2017-0178
By:
- Mooradian, Meghan J.;
- Gainor, Justin F.
Publication type:
Article
A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 784, doi. 10.1634/theoncologist.2017-0154
By:
- Lolli, Cristian;
- Gallà, Valentina;
- Schepisi, Giuseppe;
- Barone, Domenico;
- Burgio, Salvatore Luca;
- Maugeri, Antonio;
- Vertogen, Bernadette;
- Amadori, Dino;
- De Giorgi, Ugo
Publication type:
Article
FDA Approval Summary: Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 873, doi. 10.1634/theoncologist.2016-0496
By:
- Larkins, Erin;
- Blumenthal, Gideon M.;
- Yuan, Weishi;
- He, Kun;
- Sridhara, Rajeshwari;
- Subramaniam, Sriram;
- Zhao, Hong;
- Liu, Chao;
- Yu, Jingyu;
- Goldberg, Kirsten B.;
- McKee, Amy E.;
- Keegan, Patricia;
- Pazdur, Richard
Publication type:
Article
Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture-Based Assay of Circulating Tumor DNA.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 774, doi. 10.1634/theoncologist.2016-0376
By:
- Lai, Andrea Z.;
- Schrock, Alexa B.;
- Erlich, Rachel L.;
- Ross, Jeffrey S.;
- Miller, Vincent A.;
- Yakirevich, Evgeny;
- Ali, Siraj M.;
- Braiteh, Fadi
Publication type:
Article
Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 797, doi. 10.1634/theoncologist.2016-0431
By:
- Gradishar, William;
- Johnson, KariAnne;
- Brown, Krystal;
- Mundt, Erin;
- Manley, Susan
Publication type:
Article
Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 804, doi. 10.1634/theoncologist.2016-0415
By:
- Golan, Talia;
- Raitses‐Gurevich, Maria;
- Kelley, Robin K.;
- Bocobo, Andrea G.;
- Borgida, Ayelet;
- Shroff, Rachna T.;
- Holter, Spring;
- Gallinger, Steven;
- Ahn, Daniel H.;
- Aderka, Dan;
- Apurva, Jain;
- Bekaii‐Saab, Tanois;
- Friedman, Eitan;
- Javle, Milind
Publication type:
Article
Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 762, doi. 10.1634/theoncologist.2017-0152
By:
- Blumenthal, Gideon M.;
- Kluetz, Paul G.;
- Schneider, Julie;
- Goldberg, Kirsten B.;
- McKee, Amy E.;
- Pazdur, Richard
Publication type:
Article
Implementing a Fee-for-Service Cervical Cancer Screening and Treatment Program in Cameroon: Challenges and Opportunities.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 850, doi. 10.1634/theoncologist.2016-0383
By:
- DeGregorio, Geneva;
- Manga, Simon;
- Kiyang, Edith;
- Manjuh, Florence;
- Bradford, Leslie;
- Cholli, Preetam;
- Wamai, Richard;
- Ogembo, Rebecca;
- Sando, Zacharie;
- Liu, Yuxin;
- Sheldon, Lisa Kennedy;
- Nulah, Kathleen;
- Welty, Thomas;
- Welty, Edith;
- Ogembo, Javier Gordon
Publication type:
Article
Management of Treatment-Related Adverse Events with Agents Targeting the MAPK Pathway in Patients with Metastatic Melanoma.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 823, doi. 10.1634/theoncologist.2016-0456
By:
- Daud, Adil;
- Tsai, Katy
Publication type:
Article
Regarding "Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies".
Published in:
2017
By:
- Chabner, Bruce A.
Publication type:
Editorial
p16, HPV, and Cetuximab:What Is the Evidence?
Published in:
Oncologist, 2017, v. 22, n. 7, p. 811, doi. 10.1634/theoncologist.2016-0433
By:
- Bonner, James A.;
- Mesia, Ricard;
- Giralt, Jordi;
- Psyrri, Amanda;
- Keilholz, Ulrich;
- Rosenthal, David I.;
- Beier, Frank;
- Schulten, Jeltje;
- Vermorken, Jan B.
Publication type:
Article
Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 834, doi. 10.1634/theoncologist.2016-0287
By:
- Gay, Laurie M.;
- Kim, Sungeun;
- Fedorchak, Kyle;
- Kundranda, Madappa;
- Odia, Yazmin;
- Nangia, Chaitali;
- Battiste, James;
- Colon‐Otero, Gerardo;
- Powell, Steven;
- Russell, Jeffery;
- Elvin, Julia A.;
- Vergilio, Jo‐Anne;
- Suh, James;
- Ali, Siraj M.;
- Stephens, Philip J.;
- Miller, Vincent A.;
- Ross, Jeffrey S.
Publication type:
Article
Targeting BRAF-Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 786, doi. 10.1634/theoncologist.2016-0458
By:
- Baik, Christina S.;
- Myall, Nathaniel J.;
- Wakelee, Heather A.
Publication type:
Article
Amani's Silence.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 879, doi. 10.1634/theoncologist.2017-0207
By:
- Baider, Lea;
- Schapira, Lidia
Publication type:
Article
Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
Published in:
Oncologist, 2017, v. 22, n. 7, p. 780, doi. 10.1634/theoncologist.2017-0058
By:
- Abou‐Alfa, Ghassan K.;
- Blanc, Jean‐Frederic;
- Miles, Steven;
- Ganten, Tom;
- Trojan, Jörg;
- Cebon, Jonathan;
- Liem, Andre K.;
- Lipton, Lara;
- Gupta, Charu;
- Wu, Benjamin;
- Bass, Michael;
- Hollywood, Ellen;
- Ma, Jennifer;
- Bradley, Margaret;
- Litten, Jason;
- Saltz, Leonard B.
Publication type:
Article